| Q39719157 | 2 The Bio-Medical and Related Roles of Ion-Selective Membrane Electrodes |
| Q40165283 | Anaesthesia and the Kidney |
| Q40182073 | Anaesthesia for patients with chronic renal disease |
| Q40165288 | Anaesthesia for the Patient with Impaired Renal Function |
| Q36600968 | Anaesthetic considerations for microsurgical repair of limbs |
| Q39816206 | Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion |
| Q39768344 | Clinical pharmacokinetics of the inhalational anaesthetics |
| Q41428944 | Comparative tolerability profiles of the inhaled anaesthetics |
| Q33754400 | Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes |
| Q34664431 | Effect of enzyme induction on nephrotoxicity of halothane-related compounds |
| Q51843698 | Fluorinated anaesthetic nephrotoxicity: an update. |
| Q52707173 | Glomerular Filtration Rate during Enflurane Anaesthesia |
| Q41172369 | Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism |
| Q43044838 | Isoflurane compared with midazolam in the intensive care unit |
| Q42945517 | Isoflurane--a new general anesthetic for the 1980s |
| Q30403111 | Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy |
| Q51703747 | Metabolism of desflurane and isoflurane to fluoride ion in surgical patients |
| Q36753385 | Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children |
| Q34050933 | The Biochemical Basis of Anesthetic Toxicity |
| Q56474940 | The Role of Active Metabolites in Drug Toxicity |
| Q48183014 | The microcirculation during enflurane and isoflurane anaesthesia in dogs |
| Q35323911 | The use of sedative agents in critically ill patients |
| Q51734594 | Treatment with isoproterenol of bupivacaine toxicity. |